Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb;99(7):e18637.
doi: 10.1097/MD.0000000000018637.

Diode laser transscleral cyclophotocoagulation for uveitis-glaucoma-hyphema syndrome: A case report

Zhengfeng Liu  1 , Feng Zhang  2   3 , Ying Wen  4 , Xiujuan Du  4 , Xuemei Pan  4 , Hongsheng Bi  4
Affiliations
Case Reports

Diode laser transscleral cyclophotocoagulation for uveitis-glaucoma-hyphema syndrome: A case report

Zhengfeng Liu et al. Medicine (Baltimore). 2020 Feb.

Abstract

Rationale: To report a case of diode laser transscleral cyclophotocoagulation (DLTSC) for uveitis-glaucoma-hyphema syndrome (UGH).

Patient concerns: The patient developed UGH on the right eye (OD) after vitrectomy and intraocular lens (IOL) implantation.

Diagnoses: Best corrected visual acuity (BCVA) was HM/50 cm, intraocular pressure (IOP) was 51.3 mm Hg on the OD. He was found to have 3+ anterior chamber cells. A B-scan ultrasound showed vitreous opacity. Ultrasound biomicroscopy (UBM) showed the chafing between the IOL and the posterior surface of the iris. Thus, he was diagnosed as UGH on the OD.

Interventions: The patient was worried about the complications for removal of the IOL, a DLTSC approach was performed.

Outcomes: BCVA was 20/40 on the OD, IOP was 12 mm Hg on the OD. There were no anterior chamber inflammation and no vitreous opacity. UBM showed there was no contact between IOL and the posterior surface of the iris, the fundus of the eye was clearly visible.

Lessons: UGH syndrome is a severe complication of cataract extraction. IOL extraction has been the traditional approach to treatment. DLTSC can be an option when the IOL is slightly tilted.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Slit-lamp examination (A) showed 3+ anterior chamber cells on OD. B-scan ultrasound (B) showed vitreous opacity. UBM (C) showed the chafing between the IOL and the posterior surface of the iris at 5 o’clock when the eye moved. IOL = intraocular lens, OD = right eye, UBM = ultrasound biomicroscopy.
Figure 2
Figure 2
Slit-lamp examination (A) showed no anterior chamber inflammation. B-scan ultrasound (B) showed no vitreous opacity. UBM (C) showed there was no contact between IOL and the posterior surface of the iris, the fundus of the eye was clearly visible (D). IOL = intraocular lens, UBM = ultrasound biomicroscopy.
See this image and copyright information in PMC

References

    1. Ellingson FT. The uveitis-glaucoma-hyphema syndrome associated with the Mark VIII anterior chamber lens implant. J Am Intraocul Implant Soc 1978;4:50–3. - PubMed
    1. Bryant TK, Feinberg EE, Peeler CE. Uveitis-glau-coma-hyphema syndrome secondary to a Soemmerring ring. J Cataract Refract Surg 2017;43:985–7. - PubMed
    1. Sousa DC, Leal I, Faria MY, et al. A rare manifestation of uveitis-glaucoma-hyphema syndrome. J Curr Glaucoma Pract 2016;10:76–8. - PMC - PubMed
    1. Mamalis N. Explantation of intraocular lenses. Curr Opin Ophthalmol 2000;11:289–95. - PubMed
    1. Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome. J Cataract Refrac Surg 2014;40:490–2. - PubMed

Publication types